actually there are dozens of ADHD type stimulants with meaningfully distinct properties that have prescribed (or studded) in humans. Far from having picked the low hanging fruit, the FDA just… stopped picking. For example, before Ketamine was approved, the last time the FDA approved an antidepressant with a new mechanism of action, was over 50 years ago.
actually there are dozens of ADHD type stimulants with meaningfully distinct properties that have prescribed (or studded) in humans. Far from having picked the low hanging fruit, the FDA just… stopped picking. For example, before Ketamine was approved, the last time the FDA approved an antidepressant with a new mechanism of action, was over 50 years ago.
Is it an FDA issue or moreso a drug discovery issue?